BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16020670)

  • 1. Synergistic enhancement of TRAIL- and tumor necrosis factor alpha-induced cell death by a phenoxazine derivative.
    Hara K; Okamoto M; Aki T; Yagita H; Tanaka H; Mizukami Y; Nakamura H; Tomoda A; Hamasaki N; Kang D
    Mol Cancer Ther; 2005 Jul; 4(7):1121-7. PubMed ID: 16020670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer effects of phenoxazine derivatives combined with tumor necrosis factor-related apoptosis-inducing ligand on pancreatic cancer cell lines, KLM-1 and MIA-PaCa-2.
    Kato S; Shirato K; Imaizumi K; Toyota H; Mizuguchi J; Odawara M; Che XF; Akiyama S; Abe A; Tomoda A
    Oncol Rep; 2006 Apr; 15(4):843-8. PubMed ID: 16525669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity of a phenoxazine compound, 2-amino-4,4alpha-dihydro-4alpha,7-dimethyl-3H-phenoxazine-3-one against human B cell and T cell lymphoblastoid cell lines: induction of mixed types of cell death, apoptosis, and necrosis.
    Koshibu-Koizumi J; Akazawa M; Iwamoto T; Takasaki M; Mizuno F; Kobayashi R; Abe A; Tomoda A; Hamatake M; Ishida R
    J Cancer Res Clin Oncol; 2002 Jul; 128(7):363-8. PubMed ID: 12136250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenoxazine derivative, 2-amino-4,4alpha-dihydro-4alpha,7-dimethyl-3H-phenoxazine-3-one suppresses growth of human retinoblastoma cell line Y79 in vitro and in vivo.
    Kimura K; Usui Y; Hattori T; Yamakawa N; Goto H; Usui M; Okada S; Shirato K; Tomoda A
    Oncol Rep; 2008 Jan; 19(1):3-10. PubMed ID: 18097569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenoxazine derivatives 2-amino-4,4alpha-dihydro-4alpha-phenoxazine-3-one and 2-aminophenoxazine-3-one-induced apoptosis through a caspase-independent mechanism in human neuroblastoma cell line NB-1 cells.
    Shirato K; Imaizumi K; Abe A; Tomoda A
    Biol Pharm Bull; 2007 Feb; 30(2):331-6. PubMed ID: 17268075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cotreatment with histone deacetylase inhibitor LAQ824 enhances Apo-2L/tumor necrosis factor-related apoptosis inducing ligand-induced death inducing signaling complex activity and apoptosis of human acute leukemia cells.
    Guo F; Sigua C; Tao J; Bali P; George P; Li Y; Wittmann S; Moscinski L; Atadja P; Bhalla K
    Cancer Res; 2004 Apr; 64(7):2580-9. PubMed ID: 15059915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer effects of phenoxazine derivatives revealed by inhibition of cell growth and viability, disregulation of cell cycle, and apoptosis induction in HTLV-1-positive leukemia cells.
    Miyano-Kurosaki N; Ikegami K; Kurosaki K; Endo T; Aoyagi H; Hanami M; Yasumoto J; Tomoda A
    J Pharmacol Sci; 2009 May; 110(1):87-97. PubMed ID: 19403995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caspase-independent cell death revealed in human gastric cancer cell lines, MKN45 and KATO III treated with phenoxazine derivatives.
    Kasuga T; Tabuchi T; Shirato K; Imaizumi K; Tomoda A
    Oncol Rep; 2007 Feb; 17(2):409-15. PubMed ID: 17203181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bcl-2 inhibitors sensitize tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by uncoupling of mitochondrial respiration in human leukemic CEM cells.
    Hao JH; Yu M; Liu FT; Newland AC; Jia L
    Cancer Res; 2004 May; 64(10):3607-16. PubMed ID: 15150119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of novel phenoxazine compounds, 2-amino-4, 4a-dihydro-4alpha, 7-dimethyl-3H-phenoxazine-3-one and 3-amino-1, 4alpha-dihydro-4alpha, 8-dimethyl-2H-phenoxazine-2-one on proliferation of phytohemagglutinin- or anti-human IgM-activated human peripheral blood mononuclear cells.
    Akazawa M; Koshibu-Koizumi J; Iwamoto T; Takasaki M; Nakamura M; Tomoda A
    Tohoku J Exp Med; 2002 Mar; 196(3):185-92. PubMed ID: 12002275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor effects of a novel phenoxazine derivative on human leukemia cell lines in vitro and in vivo.
    Shimamoto T; Tomoda A; Ishida R; Ohyashiki K
    Clin Cancer Res; 2001 Mar; 7(3):704-8. PubMed ID: 11297267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential.
    Hotta T; Suzuki H; Nagai S; Yamamoto K; Imakiire A; Takada E; Itoh M; Mizuguchi J
    J Orthop Res; 2003 Sep; 21(5):949-57. PubMed ID: 12919886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 15-Deoxy-Delta12,14-prostaglandin J(2) induces death receptor 5 expression through mRNA stabilization independently of PPARgamma and potentiates TRAIL-induced apoptosis.
    Nakata S; Yoshida T; Shiraishi T; Horinaka M; Kouhara J; Wakada M; Sakai T
    Mol Cancer Ther; 2006 Jul; 5(7):1827-35. PubMed ID: 16891469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Aminophenoxazine-3-one and 2-amino-4,4α-dihydro-4α,7-dimethyl-3H-phenoxazine-3-one cause cellular apoptosis by reducing higher intracellular pH in cancer cells.
    Che XF; Zheng CL; Akiyama S; Tomoda A
    Proc Jpn Acad Ser B Phys Biol Sci; 2011; 87(4):199-213. PubMed ID: 21558757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-Methoxy-canthin-6-one induces c-Jun NH2-terminal kinase-dependent apoptosis and synergizes with tumor necrosis factor-related apoptosis-inducing ligand activity in human neoplastic cells of hematopoietic or endodermal origin.
    Ammirante M; Di Giacomo R; De Martino L; Rosati A; Festa M; Gentilella A; Pascale MC; Belisario MA; Leone A; Turco MC; De Feo V
    Cancer Res; 2006 Apr; 66(8):4385-93. PubMed ID: 16618764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of the proliferation of cancer cell lines, KB-3-1 and K562 cells preceded by a decrease in intracellular pH caused by phenoxazine derivatives.
    Che XF; Akiyama S; Tomoda A
    Oncol Rep; 2008 May; 19(5):1253-8. PubMed ID: 18425384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
    Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
    Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel phenoxazine derivative suppresses proliferation of human endometrial adenocarcinoma cell lines, inducing G2M accumulation and apoptosis.
    Nakada T; Isaka K; Nishi H; Osakabe Y; Shimamoto T; Ohyashiki K; Tomoda A; Takayama M
    Oncol Rep; 2003; 10(5):1171-6. PubMed ID: 12883676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac glycosides initiate Apo2L/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5.
    Frese S; Frese-Schaper M; Andres AC; Miescher D; Zumkehr B; Schmid RA
    Cancer Res; 2006 Jun; 66(11):5867-74. PubMed ID: 16740726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperative cytotoxicity of proteasome inhibitors and tumor necrosis factor-related apoptosis-inducing ligand in chemoresistant Bcl-2-overexpressing cells.
    Nencioni A; Wille L; Dal Bello G; Boy D; Cirmena G; Wesselborg S; Belka C; Brossart P; Patrone F; Ballestrero A
    Clin Cancer Res; 2005 Jun; 11(11):4259-65. PubMed ID: 15930365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.